Article Details

Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT ...

Retrieved on: 2021-04-10 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT .... View article details on hiswai:

Excerpt

“The ability of Immunosynthen-based ADCs to activate the innate immune system via STING in tumor cells in addition to tumor-resident immune cells ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up